We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IG:MILItalgas SpA Analysis

Data as of 2026-08-25 - not real-time

€8.84

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Italgas S.p.A. is priced at €8.84 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 11.6% over the past 30 days. RSI sits at 38.4, which reads as approaching oversold, and MACD momentum is bullish. Watch €8.60 as support and €10.13 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 12.6 versus a 19.7 sector average, below the peer group. Sell-side targets cluster 21.0% above the current quote. Revenue is growing at 30.6% on a 18.7% profit margin. The 4.92% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 23.5%, a beta of 0.15 and a maximum drawdown of 23.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top Market Events

Seeking Alpha28dItalgas S.p.A. ITGGF Q2 2026 Earnings Call TranscriptGood afternoon. This is the Chorus Call conference...Yahoo Finance1monEarnings To Watch: Italgas SpA MIL:IG Reports Q2 2026 ResultBased on the one-year price targets...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 9.98
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 12.6 versus sector average of 19.7
  • Trading below the 200-day average of 9.98

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.6 versus sector average of 19.7
  • Analyst targets imply +21.0% versus the current price
  • Profit margin of 18.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth30.60%
Profit Margin18.70%
P/E Ratio12.6
ROE19.06%
ROA4.32%
Debt/Equity294.06
P/B Ratio2.4
Op. Cash Flow€1.8B
Free Cash Flow€305.1M
Industry P/E19.7

Technical Analysis

TrendBearish
RSI38.4
Support€8.60
Resistance€10.13
MA 20€8.91
MA 50€9.69
MA 200€9.98
MACDBullish
VolumeDecreasing
Fear & Greed Index93.82

Valuation

Target Price€10.69
Upside/Downside20.99%
GradeUndervalued
TypeBlend
Dividend Yield4.92%

Risk Assessment

Beta0.15
Volatility23.46%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.